[Preliminary study of the tolerance of 3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate (I. 612) and on its effects on plasma lipid pattern, hemostasis and clotting-fibrinolysis balance].
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects*; D002994:Clofibrate / Q000031:analogs & derivatives* / Q000494:pharmacology; D004361:Drug Tolerance; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000494:pharmacology
D008055:Lipids; D009539:Nicotinic Acids; D002994:Clofibrate
Indagine preliminare circa la tollerabilità del p-clorofenossi-isobutirrato di 3-nicotinoil-ossipropile (I. 612) e circa i suoi effetti sull'assetto lipidico plasmatico, sull'emostasi e sull'equilibrio coagulativo-fibrinolitico.